Showing 1 - 2 results of 2 for search 'Zhengyang Fei', query time: 0.03s Refine Results
  1. 1
    The Relationship Between Short-Term Surrogate Endpoint Indicators and mPFS and mOS in Clinical Trials of Malignant Tumors: A Case Study of Approved Molecular Targeted Drugs for Non-Small-Cell Lung Cancer in China

    The Relationship Between Short-Term Surrogate Endpoint Indicators and mPFS and mOS in Clinical Trials of Malignant Tumors: A Case Study of Approved Molecular Targeted Drugs for Non... by Mingjun Rui, Mingjun Rui, Zijing Wang, Zijing Wang, Zhengyang Fei, Zhengyang Fei, Yao Wu, Yao Wu, Yingcheng Wang, Yingcheng Wang, Lei Sun, Ye Shang, Ye Shang, Hongchao Li, Hongchao Li

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Cost-effectiveness analysis of tislelizumab vs. camrelizumab for the treatment of second-line locally advanced or metastatic esophageal squamous cell carcinoma

    Cost-effectiveness analysis of tislelizumab vs. camrelizumab for the treatment of second-line locally advanced or metastatic esophageal squamous cell carcinoma by Pingyu Chen, Chang Fu, Lin Shen, Zhengyang Fei, Mengjie Luo, Yanqiu Chen, Hongchao Li

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: